This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 20 and 40
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection (piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under fasting conditions.

Provided treatments

  • Drug: Tapimycin (piperacillin 4 g + tazobactam 0.5g)
Tris trial is registered with FDA with number: NCT00924742. The sponsor of the trial is Tri-Service General Hospital and it is looking for 12 volunteers for the current phase.
Official trial title:
A Single-Dose Pharmacokinetics Study of Tapimycin Injection(Piperacillin 4 g + Tazobactam 0.5 g Powder for Injection) Administered Under Fasting Conditions to Healthy Adult Subjects